Analysis of the Clinical Application Value of Colposcopy Biopsy in the Screening of Cervical Precancerous Lesions
Download PDF

Keywords

Cervical cancer
Precancerous lesions
Colposcopy biopsy
Clinical value

DOI

10.26689/aogr.v1i2.5180

Submitted : 2023-08-22
Accepted : 2023-09-06
Published : 2023-09-21

Abstract

Objective: To analyze the value of colposcopy biopsy in the screening of cervical precancerous lesions. Methods: 5,000 patients with suspected cervical precancerous lesions were used as samples. From January 2020 to December 2022, pathological examination and colposcopy biopsy were carried out, and the value of colposcopy biopsy was analyzed. Results: 1,503 cases were positive and 3,497 cases were negative by pathology, whereas 1,432 cases were positive and 3,568 cases were negative by colposcopy biopsy. The diagnostic sensitivity, specificity, and accuracy of colposcopy biopsy were 99.69%, 94.54%, and 97.78%, respectively. Cervicitis, CIN Ⅰ grade, CIN Ⅱ grade, CIN Ⅲ grade, and cervical cancer had no statistical difference with the pathological examination (P > 0.05). Conclusion: The colposcopy biopsy scheme is used in the screening of cervical precancerous lesions, the detection accuracy is high in consistency with the pathological results, the risk of missed diagnosis and misdiagnosis is low, and it is efficient and feasible.

References

Xiao X, Jiang E, Yao X, 2022, Analysis of the Diagnostic Value of Colposcopy Biopsy in Cervical Cancer Screening. Chinese and Foreign Women’s Health Research, 8(19): 183–185.

Ding Y, Fang P, Li H, 2022, Exploring the Clinical Application Value of Four-Quadrant Biopsy under Colposcopy in Cervical Cancer Screening. Modern Diagnosis and Treatment, 33(7): 1047–1050.

Wu Q, Liu K, 2022, The Application Value of Liquid-Based Thin-Layer Cytology Detection, Human Papillomavirus Detection and Colposcopy in the Screening of Cervical Precancerous Lesions and Cervical Cancer. Chinese Contemporary Medicine, 29(32): 101–104.

Yang J, 2022, The Application Effect of Cervical Biopsy under Colposcopy in the Screening of Cervical Precancerous Lesions. Chinese Science and Technology Journal Database Medicine and Health, 7(11): 130–133.

Zeng Y, 2022, The Diagnostic Value of Colposcopy Biopsy, Ki-67, VEGF, OLFM4 in Cervical Cancer and Precancerous Lesions. Chinese Medicine Innovation, 19(10): 123–127.

Zou H, Li Q, Xu M, 2022, The Value of High-Risk HPV-DNA Typing Combined with TCT and Colposcopy in the Early Screening of Cervical Precancerous Lesions. Shenzhen Journal of Integrated Traditional Chinese and Western Medicine, 32(20): 5–8.

He S, Jiang W. 2022, The Clinical Significance of TCT, HPV Detection and Colposcopy in the Screening of Cervical Precancerous Lesions and Cervical Cancer. Practical Gynecological Endocrinology Electronic Journal, 9(20): 67–70.

Zhang X, 2020, The Clinical Application Value of TCT Combined with Colposcopy in the Screening of Cervical Cancer and Precancerous Lesions. Electronic Journal of Modern Medicine and Health Research, 4(7): 69–71.

Wu H, 2021, The Clinical Value of HPV and TCT Detection Combined with Colposcopy Positioning Biopsy in the Screening of Cervical Cancer and Precancerous Lesions. My Baby and I, 11(8): 36–37.

Song Y, Liu G, 2020, Exploring the Application Value of Biopsy of Suspicious Lesions under Colposcope in the Screening of Cervical Precancerous Lesions. Great Doctor, 5(21): 94–96.

Li N, 2022, Clinical Diagnostic Value of Colposcopy TCT, Biopsy and HPV Detection for Cervical Lesions. Contemporary Medicine, 28(4): 115–117.

Zhao Y, Hu X, 2022, Analysis of Diagnostic Efficiency and Missed Diagnosis Factors of Cervical Precancerous Lesions by Colposcopy Cervical Biopsy. Harbin Medicine, 42(5): 28–31.

Yu X, Wang X, 2022, Analysis of the Diagnostic Value of Cervical Cytology Combined with Colposcopy in Cervical Cancer Screening. Electronic Journal of Practical Gynecological Endocrinology, 9(16): 92–94.

Jin D, Sang Z, 2022, Analysis of the Clinical Effect of Cervical Liquid-Based Cytology Detection Combined with Colposcopy Cervical Resection for Cervical Cancer Screening. Contemporary Medicine, 28(7): 40–42.